Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452

The Statistical Analysis of Failure Time Data.

Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875

Validation of a combined comorbidity index

Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587

International scoring system for evaluating prognosis in myelodysplastic syndromes

Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427

Regression modelling strategies for improved prognostic prediction

Harrell, F. E., Lee, K. L., Califf, R. M., Pryor, D. B., & Rosati, R. A. (1984) · Statistics in Medicine · doi:10.1002/sim.4780030207 · Cited by 1,804

Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives

Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717

The pre-therapeutic classification of co-morbidity in chronic disease

Feinstein, A. R. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90054-8 · Cited by 1,544

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

Storb, R. F., Deeg, H. J., Whitehead, J., Appelbaum, F. R., Beatty, P. G., Bensinger, W., Buckner, C. D., Clift, R. A., Doney, K., Farewell, V. T., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141201 · Cited by 1,411

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

McSweeney, P. A., Niederwieser, D. W., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,386

Influence of Pretransplantation Restrictive Lung Disease on Allogeneic Hematopoietic Cell Transplantation Outcomes

Ramírez-Sarmiento, A., Orozco‐Levi, M., Walter, E. C., Au, M. A., & Chien, J. W. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2009.09.016 · Cited by 23

The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma

van Besien, K. (2006) · Blood Reviews · doi:10.1016/j.blre.2006.01.001 · Cited by 23

Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity

Cheminant, M., Fox, T. A., Alligon, M., Bouaziz, O., Neven, B., Moshous, D., Blanche, S., Guffroy, A., Fieschi, C., Malphettes, M., et al. (2022) · Blood · doi:10.1182/blood.2022015482 · Cited by 22

Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT

Takano, K., Fuji, S., Uchida, N., Ogawa, H., Ohashi, K., Eto, T., Sakamaki, H., MORISHIMA, Y., Kato, K., Suzuki, R., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.315 · Cited by 22

High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma

Martin, N., Borchiellini, D., Coso, D., Gastaud, L., Boscagli, A., Saudes, L., Ré, D., Gutnecht, J., Garnier, G., Petit, E., et al. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.1001987 · Cited by 22

Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation

Oran, B., Jiménez, A., Lima, M. J. G. D., Popat, U., Bassett, R., Andersson, B. S., Borthakur, G. M., Bashir, Q., Chen, J. J., Ciurea, S. O., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.03.023 · Cited by 22

The molecular basis of familial chronic lymphocytic leukemia

Crowther-Swanepoel, D., & Houlston, R. S. (2009) · Haematologica · doi:10.3324/haematol.2009.006296 · Cited by 22

Donor Type and Disease Risk Predict the Success of Allogeneic Hematopoietic Cell Transplantation: A Single-Center Analysis of 613 Adult Hematopoietic Cell Transplantation Recipients Using a Modified Composite Endpoint

Solh, M., Zhang, X., Connor, K., Brown, S. L., Morris, L. E., Holland, H. K., Bashey, A., & Solomon, S. R. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.08.030 · Cited by 22

The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index

Efficace, F., Cottone, F., Oswald, L. B., Cella, D. F., Patriarca, A., Niscola, P., Breccia, M., Platzbecker, U., Palumbo, G. A., Caocci, G., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0746-8 · Cited by 22

Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics

Roussel, X., Daguindau, É., Berceanu, A., Desbrosses, Y., Warda, W., Rocha, M. N. D., Trad, R., Deconinck, É., Deschamps, M., & Ferrand, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.599933 · Cited by 24

Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Pidala, J., Walton, K., Elmariah, H., Kim, J., Mishra, A., Bejanyan, N., Nishihori, T., Khimani, F., Perez, L. E., Faramand, R. G., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4725 · Cited by 22

Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia

Loke, J. C. T., Vyas, H., & Craddock, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.666091 · Cited by 22

Incidence and Risk Factors for Acute Kidney Injury after Allogeneic Stem Cell Transplantation: A Prospective Study

Andronesi, A. G., Sorohan, B. M., Burcea, A.-F., Lipan, L. E., Stanescu, C., Craciun, O., Stefan, L., Ranete, A., Várady, Z., Ungureanu, O., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10020262 · Cited by 22

Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status

Konuma, T., Yamasaki, S., Ishiyama, K., Mizuno, S., Hayashi, H., Uchida, N., Shimabukuro, M., Tanaka, M., Kuriyama, T., Onizuka, M., et al. (2023) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2023.12.002 · Cited by 22

Allogeneic haematopoietic cell transplantation with reduced‐intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study

Aoki, K., Ishikawa, T., Ishiyama, K., Aoki, J., Itonaga, H., Fukuda, T., Kakihana, K., Uchida, N., Ueda, Y., Eto, T., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.13124 · Cited by 22

Comparison of a fludarabine and melphalan combination‐based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents

Ishida, H., Adachi, S., Hasegawa, D., Okamoto, Y., Goto, H., Inagaki, J., Inoue, M., Koh, K., Yabe, H., Kawa, K., et al. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25389 · Cited by 22

Eosinophilia predicts better overall survival after acute graft-versus-host-disease

Imahashi, N., Miyamura, K., Seto, A., Watanabe, K., Yanagisawa, M., Nishiwaki, S., Shinba, M., Yasuda, T., Kuwatsuka, Y., Terakura, S., et al. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.135 · Cited by 22

Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype

Virijević, M., Karan-Djurašević, T., Marjanović, I., Tos̆ić, N., Mitrović, M., Đjunić, I., Čolović, N., Vidović, A., Suvajdžić, N., Tomin, D., et al. (2016) · Radiology and Oncology · doi:10.1515/raon-2016-0044 · Cited by 22

Aging: Treating the Older Patient

Rosko, A. E., & Artz, A. S. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.11.007 · Cited by 22

Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients

Solh, M., Bashey, A., Solomon, S. R., Morris, L. E., Zhang, X., Brown, S. L., & Holland, H. K. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-017-0076-2 · Cited by 22

Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation

Bejanyan, N., Brunstein, C. G., Cao, Q., Lazaryan, A., Üstün, C., Warlick, E. D., Arora, M., Wagner, J. E., & Weisdorf, D. J. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018018549 · Cited by 22

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2014

Appelbaum, F. R., Anasetti, C., Antin, J. H., Atkins, H. L., Davies, S. M., Devine, S. M., Giralt, S., Heslop, H. E., Laport, G. G., Lee, S. J., et al. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.10.003 · Cited by 22

Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease

Saraf, S. L., & Rondelli, D. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101565 · Cited by 24

Extra-medullary recurrence of myeloid leukemia as myeloid sarcoma after allogeneic stem cell transplantation: impact of conditioning intensity

Frietsch, J. J., Hunstig, F., Wittke, C., Junghanß, C., Franiel, T., Scholl, S., Hochhaus, A., & Hilgendorf, I. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-0984-4 · Cited by 22

Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States

Hong, S., Brazauskas, R., Hebert, K. M., Ganguly, S., Abdel‐Azim, H., Díaz, M. Á., Beattie, S., Ciurea, S. O., Szwajcer, D., Badawy, S. M., et al. (2020) · Cancer · doi:10.1002/cncr.33232 · Cited by 22

High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma

Lahoud, O. B., Sauter, C. S., Hamlin, P. A., & Dahi, P. B. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0465-x · Cited by 22

Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato‐oncological patients: Randomized controlled trial

Paul, M., Ram, R., Kugler, E., Farbman, L., Peck, A., Leibovici, L., Lahav, M., Yeshurun, M., Shpilberg, O., Herscovici, C., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23622 · Cited by 22

Syngeneic Donor Hematopoietic Stem Cell Transplantation Is Associated with High Rates of Engraftment Syndrome

Koreth, J., Biernacki, M. A., Aldridge, J., Kim, H. T., Alyea, E. P., Armand, P. A., Cutler, C. S., Ho, V. T., Wu, C. J., Antin, J. H., et al. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.09.013 · Cited by 22

Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival

Scheich, S., Koenig, R., Wilke, A. C., Lindner, S., Reinheimer, C., Wichelhaus, T. A., Hogardt, M., Kempf, V. A. J., Kessel, J. M., Weber, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201169 · Cited by 22

Protective Effect of Intestinal Blautia Against Neutropenic Fever in Allogeneic Transplant Recipients

Rashidi, A., Peled, J. U., Ebadi, M., Rehman, T. U., Elhusseini, H., Marcello, L. T., Halaweish, H., Kaiser, T., Holtan, S. G., Khoruts, A., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac299 · Cited by 21

Longitudinal clinical data improve survival prediction after hematopoietic cell transplantation using machine learning

Zhou, Y., Smith, J. L., Keerthi, D., Li, C., Sun, Y., Mothi, S. S., Shyr, D. C., Spitzer, B. G., Harris, A. C., Chatterjee, A., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023011752 · Cited by 21

Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704

Sorror, M. L., Saber, W., Logan, B. R., Geller, N. L., Bellach, A., Kou, J., Wood, W. A., McCarty, J. M., Knight, T. G., Runaas, L., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2025015793 · Cited by 21

Janus Kinase Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis

Gupta, V. K., Gotlib, J. R., Radich, J. P., Kröger, N. M., Rondelli, D., Verstovšek, S., & Deeg, H. J. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.03.017 · Cited by 22

Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom?

Vaughn, J. E., Anwer, F., & Deeg, H. J. (2015) · Vox Sanguinis · doi:10.1111/vox.12314 · Cited by 21

Reduced-intensity and myeloablative conditioning allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome: a meta-analysis and systematic review.

Zeng, W., Huang, L., Meng, F., Liu, Z., Zhou, J., & Sun, H. (2014) · Europe PMC (PubMed Central) · Cited by 21

Allogeneic transplant: does age still matter?

Zuckerman, T. (2017) · Blood · doi:10.1182/blood-2017-07-795948 · Cited by 21

Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5‐year analysis within the Swiss Transplant Cohort study

Vu, D., Dayer, J.-A., Masouridi‐Levrat, S., Combescure, C., Boely, E., Khanna, N., Mueller, N. J., Kleber, M., Medinger, M., Halter, J. P., et al. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13289 · Cited by 21

Treatment with Foscarnet after Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Is Associated with Long-Term Loss of Renal Function

Foster, G. G., Grant, M. J., Thomas, S. M., Cameron, B., Raiff, D., Corbet, K., Loitsch, G., Ferreri, C., & Horwitz, M. E. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.05.007 · Cited by 21

Free of malignancy but not of fears: A closer look at Damocles syndrome in survivors of hematologic malignancies

Alabdaljabar, M. S., Muhsen, I. N., Knight, J. M., Syrjala, K. L., & Hashmi, S. K. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100783 · Cited by 22

Impact of comorbidities and body mass index on the outcome of polycythemia vera patients

Benevolo, G., Elli, E. M., Bartoletti, D., Latagliata, R., Tiribelli, M., Heidel, F. H., Cavazzini, F., Bonifacio, M., Crugnola, M., Binotto, G., et al. (2021) · Hematological Oncology · doi:10.1002/hon.2843 · Cited by 21

Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell Transplantation

Brauer, D., Backhaus, D., Pointner, R., Vučinić, V., Niederwieser, D. W., Platzbecker, U., Schwind, S., & Jentzsch, M. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000532 · Cited by 21

Comparison of the prognostic significance of 5 comorbidity scores and 12 functional tests in a prospective multiple myeloma patient cohort

Scheubeck, S., Ihorst, G., Schoeller, K., Holler, M., Möller, M., Reinhardt, H., Wäsch, R., & Engelhardt, M. M. (2021) · Cancer · doi:10.1002/cncr.33658 · Cited by 21

Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation

Sidana, S., Kumar, S. K., Fraser, R. A., Estrada‐Merly, N., Giralt, S., Agrawal, V., Anderson, L. D., Aljurf, M. D., Banerjee, R. K., Bashey, A., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.10.022 · Cited by 25

Social Vulnerability and Risk of Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation

Bhandari, R., Teh, J. B., He, T., Nakamura, R., Artz, A. S., Jankowska, M. M., Forman, S. J., Wong, F. L., & Armenian, S. H. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac150 · Cited by 21

Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission

Yanada, M., Yamasaki, S., Kondo, T., Kawata, T., Harada, K., Uchida, N., Doki, N., Yoshihara, S., Katayama, Y., Eto, T., et al. (2023) · Leukemia · doi:10.1038/s41375-023-02119-0 · Cited by 21

Outcomes of patients with therapy-related AML/myelodysplastic syndrome (t-AML/MDS) following hematopoietic cell transplantation

Alam, N., Atenafu, E. G., Kuruvilla, J. G., Uhm, J., Lipton, J. H., Messner, H. A., Kim, D. H., Seftel, M. D., & Gupta, V. K. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.151 · Cited by 21

Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic cell transplantation

Hamilton, B. K., Rybicki, L. A., Dabney, J., McLellan, L. J., Haddad, H., Foster, L., Abounader, D., Kalaycio, M. E., Sobecks, R. M., Dean, R. M., et al. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.166 · Cited by 21

Haploidentical hematopoietic stem cell transplantation to adults with hematologic malignancies: analysis of 66 cases at a single Japanese center

Kurokawa, T., Ishiyama, K., Ozaki, J., Yamashita, Y., Iwaki, N., Saito, C., Arahata, M., Kaya, H., & Yoshida, T. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0561-5 · Cited by 21

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective

Yanada, M. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1657-0 · Cited by 21

Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention

Khimani, F., Kim, J., Chen, L., Dean, E. A., Rizk, V. T., Betts, B. C., Nishihori, T., Locke, F. L., Mishra, A., Perez, L. E., et al. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2017.63 · Cited by 21

FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients

Delia, M., Pastore, D., Carluccio, P., Pasciolla, C., Ricco, A., Rossi, A. R., Casieri, P., Mestice, A., Albano, F., & Specchia, G. (2017) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2017.06.002 · Cited by 21

Overview of Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies

Singh, N., & Loren, A. W. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.07.001 · Cited by 23

Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation

Farowski, F., Bücker, V., Vehreschild, J. J., Biehl, L. M., Aguilar, R. C., Scheid, C., Holtick, U., Jazmati, N., Wisplinghoff, H., Cornely, O. A., et al. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2017.203 · Cited by 21

CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Barba, P., Martino, R., Zhou, Q. C., Cho, C., Castro-Malaspina, H. R., Devlin, S. M., Esquirol, A., Giralt, S. A., Jakubowski, A. A., Caballero, D. M., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.12.804 · Cited by 21

Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Malki, M. M. A., Nathwani, N., Yang, D., Armenian, S. H., Dadwal, S., Salman, J., Mokhtari, S., Cao, T. M., Sandhu, K., Rouse, M., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.04.029 · Cited by 21

Propensity Score Analysis of Conditioning Intensity in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation

Huselton, E. J., Slade, M., Trinkaus, K. M., DiPersio, J. F., Westervelt, P., & Romee, R. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.05.024 · Cited by 21

Psychosocial Assessment of Candidates for Transplantation scale (PACT) and survival after allogeneic hematopoietic stem cell transplantation

Harashima, S., Yoneda, R., Horie, T., Fujioka, Y., Nakamura, F., Kurokawa, M., & Yoshiuchi, K. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0371-6 · Cited by 23

Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources

Elsawy, M., Storer, B. E., Milano, F., Sandmaier, B. M., Delaney, C. S., Salit, R. B., Rashad, A. H., Woolfrey, A. E., Appelbaum, F. R., Storb, R. F., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.11.030 · Cited by 21

Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients

Inamoto, Y., White, J., Ito, R., Martin, P. J., Fatobene, G., Ito, A., Tanaka, T., Kurosawa, S., Kim, S., Bar, M., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000386 · Cited by 21

Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial

Popat, U., Mehta, R. S., Bassett, R. L., Kongtim, P., Chen, J. J., Alousi, A. M., Anderlini, P. N., Ciurea, S. O., Hosing, C. M., Jones, R. B., et al. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.03.020 · Cited by 21

Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health

Wolff, D., Herzberg, P. Y., Herrmann, A., Pavletic, S. Z., Heußner, P., Mumm, F., Höfer, C., Hilgendorf, I., Hemmati, P., Holler, E., et al. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-01017-8 · Cited by 21

CELL THERAPY IN INFLAMMATORY BOWEL DISEASE

Cassinotti, A., Passamonti, F., & Segato, S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105247 · Cited by 22

Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal

Valentini, C. G., Chiusolo, P., Bianchi, M., Metafuni, E., Orlando, N., Giammarco, S., Bacigalupo, A. P., Sica, S., & Teofili, L. (2020) · Cytotherapy · doi:10.1016/j.jcyt.2020.12.001 · Cited by 21

The evolving concept of indications for allogeneic hematopoietic cell transplantation during first complete remission of acute myeloid leukemia

Yanada, M. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01247-4 · Cited by 21

Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for De Novo Acute Myelogenous Leukemia with a Conditioning Regimen of Total Body Irradiation and Granulocyte Colony-Stimulating Factor-Combined High-Dose Cytarabine

Mori, T., Aisa, Y., Watanabe, R., Yamazaki, R., Kato, J., Shimizu, T., Shigematsu, N., Kubo, A., Yajima, T., Hibi∥, T., et al. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.03.006 · Cited by 21

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia

Veltri, L. W., Rezvani, K., Oran, B., Mehta, R. S., Rondón, G., Kebriaei, P., Popat, U., Nieto, Y. L., Hosing, C. M., Qazilbash, M. H., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.09.032 · Cited by 21

Evolving strategies for addressing CAR T-cell toxicities

Rankin, A. W., Duncan, B. B., Allen, C., Silbert, S. K., & Shah, N. N. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10227-1 · Cited by 22

Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia

Lodewyck, T., Oudshoorn, M., van der Holt, B., Petersen, E. J., Spierings, E., Borne, P. A. V. D., Schattenberg, A. V. M. B., Allebes, W. A., Groenendijk-Sijnke, M., Duinhouwer, L. E., et al. (2011) · Leukemia · doi:10.1038/leu.2011.123 · Cited by 20

Outcomes of elderly de novo acute myeloid leukemia treated by a risk‐adapted approach based on age, comorbidity, and performance status

Yoon, J., Cho, B., Kim, H., Kim, J. H., Shin, S., Yahng, S., Lee, S., Eom, K., Kim, Y., Lee, S., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23576 · Cited by 20

Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma

Bhatt, V. R. (2016) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-016-0319-0 · Cited by 20

Prognostic Index for Critically Ill Allogeneic Transplantation Patients

Bayraktar, U. D., Milton, D. R., Shpall, E. J., Rondón, G., Price, K., Champlin, R. E., & Nates, J. L. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.03.003 · Cited by 20

Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease–Free, Failure-Free Survival Rate

Park, S., Kwak, D. H., Jeon, Y., Yoon, J., Lee, S., Cho, B., Eom, K., Kim, Y., Kim, H., Lee, S., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.05.026 · Cited by 20

Integration of neuronal and glial signalling by pyramidal cells of the rat prefrontal cortex; control of cognitive functions and addictive behaviour by purinergic mechanisms.

Krügel, U., Köles, L., & Illés, P. (2013) · PubMed · Cited by 20

Use of comorbidity indices in patients with any cancer, breast cancer, and human epidermal growth factor receptor-2-positive breast cancer: A systematic review

Salas, M., Henderson, M., Sundararajan, M., Tu, N., Islam, Z., Ebeid, M., & Horne, L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252925 · Cited by 20

Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021

Urbino, I., Secreto, C., Olivi, M., Apolito, V., D’Ardìa, S., Frairia, C., Giai, V., Aydin, S., Freilone, R., Dellacasa, C. M., et al. (2021) · Cancers · doi:10.3390/cancers13205075 · Cited by 20

Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen

Versluys, B. A. B., de Koning, C. C. H., Lankester, A. C., Nierkens, S., Kollen, W. J. W., Bresters, D., Lindemans, C. A., Boelens, J. J., & Bierings, M. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005224 · Cited by 20

Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

Zarling, L. C., Othus, M. K. D., Sandmaier, B. M., Milano, F., Schoch, G. H., Davis, C., Bleakley, M., Deeg, H. J., Appelbaum, F. R., Storb, R. F., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01574-5 · Cited by 20

The Use of Prognostic Models in Allogeneic Transplants: A Perspective Guide for Clinicians and Investigators

Sorror, M. L. (2023) · Blood · doi:10.1182/blood.2022017999 · Cited by 19

Restrictive Versus Permissive Use of Broad-spectrum Antibiotics in Patients Receiving Allogeneic Stem Cell Transplantation and With Early Fever Due to Cytokine Release Syndrome: Evidence for Beneficial Microbiota Protection Without Increase in Infectious Complications

Weber, D., Hiergeist, A., Weber, M., Ghimire, S., Salzberger, B., Wolff, D., Poeck, H., Gessner, A., Edinger, M., Herr, W., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad389 · Cited by 20

Analysis benefits of a second Allo-HSCT after CAR-T cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who relapsed after transplant

Cao, X., Zhang, J., Zhao, Y., Xiong, M., Zhou, J., Lü, Y., Sun, R., Wei, Z., Liu, D., Zhang, X., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1191382 · Cited by 20

The European Society for Blood and Marrow Transplantation (EBMT) roadmap and perspectives to improve nutritional care in patients undergoing hematopoietic stem cell transplantation on behalf of the Cellular Therapy and Immunobiology Working Party (CTIWP) and the Nurses Group (NG) of the EBMT

Casirati, A., Salcedo, I., Cereda, E., Chabannon, C., Ruggeri, A., Kuball, J. H. E., Clout, R., Mooyaart, J., Kenyon, M., Caccialanza, R., et al. (2023) · Bone Marrow Transplantation · doi:10.1038/s41409-023-02018-z · Cited by 22

Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study

Juárez, A., Salas, M. Q., Pedraza, A., Suárez‐Lledó, M., Rodríguez‐Lobato, L. G., Solano, M. T., Serrahima, A., Nomdedéu, M., Cid, J., Lozano, M., et al. (2024) · Cancers · doi:10.3390/cancers16142567 · Cited by 20

Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML

Ali, N. J., Othus, M. K. D., Arboli, E. R., Orvain, C., Milano, F., Sandmaier, B. M., Davis, C., Basom, R., Appelbaum, F. R., & Walter, R. B. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024013214 · Cited by 20

Time changes in predictive power of established and recently proposed clinical, cytogenetical and comorbidity scores for Myelodysplastic Syndromes

Pfeilstöcker, M., Tüchler, H., Schönmetzler, A., Nösslinger, T., & Pittermann, E. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.09.007 · Cited by 20

Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors

Langston, A. A., Prichard, J. M., Muppidi, S., Nooka, A. K., Lechowicz, M. J., Lonial, S., Sinha, R., Graiser, M., Kaufman, J. L., Khoury, H. J., et al. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2013.168 · Cited by 20

Minimal residual disease detectable by quantitative assessment of WT 1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis

Válková, V., Polák, J., Marková, M., Vı́tek, A., Hájková, H., Šálek, C., Procházka, B., Cetkovský, P., & Trněný, M. (2012) · Clinical Transplantation · doi:10.1111/ctr.12046 · Cited by 20

Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites

Hamilton, B. K., Rybicki, L. A., Sekeres, M. A., Kalaycio, M. E., Hanna, R., Sobecks, R. M., Dean, R. M., Duong, H., Hill, B. T., Bolwell, B. J., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.44 · Cited by 20

Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens

Torra, O. S., Martin, P. J., Storer, B. E., Traina, F., Sorror, M. L., Storb, R. F., Sandmaier, B. M., & Flowers, M. E. D. (2008) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705987 · Cited by 20

Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: longitudinal analysis from 1994 to 2008 at a single institution

Martino, R., Kerguelen, A., Valcárcel, D., Sureda, A. M., Fachini, L., Piñana, J. L., Briones, J., Delgado, J., Brunet, S., & Sierra, J. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.177 · Cited by 20

Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Cazzola, M. (2011) · Haematologica · doi:10.3324/haematol.2010.030023 · Cited by 20

Myeloablative versus Reduced-Intensity Conditioning in Patients with Myeloid Malignancies: A Propensity Score-Matched Analysis

Sibai, H. A., Falcone, U., Deotare, U. R., Michelis, F. V., Uhm, J., Gupta, V. K., Kuruvilla, J. G., Lipton, J. H., Seftel, M. D., Messner, H. A., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.08.030 · Cited by 20

Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost‐effective

Reid, R. M., Baran, A. M., Friedberg, J. W., Phillips, G. L., Liesveld, J. L., Becker, M. W., Wedow, L., Barr, P. M., & Milner, L. A. (2016) · Cancer Medicine · doi:10.1002/cam4.879 · Cited by 22

History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease‐negative first complete remission

Rashidi, A., Linden, M. A., DeFor, T. E., Warlick, E. D., Bejanyan, N., Yohe, S. L., Weisdorf, D. J., & Üstün, C. (2017) · American Journal of Hematology · doi:10.1002/ajh.24834 · Cited by 20

Impact of comorbidities constituting the hematopoietic cell transplant (HCT)‐comorbidity index on the outcome of patients undergoing allogeneic HCT for acute myeloid leukemia

Khalil, M. M. I., Lipton, J. H., Atenafu, E. G., Gupta, V. K., Kim, D. D. H., Kuruvilla, J. G., Viswabandya, A., Messner, H. A., & Michelis, F. V. (2017) · European Journal Of Haematology · doi:10.1111/ejh.13000 · Cited by 20

Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies

Chevallier, P., Péterlin, P., Garnier, A., Bourgeois, A. L., Mahé, B., Dubruille, V., Blin, N., Touzeau, C., Gastinne, T., Lok, A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26083 · Cited by 20

Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models

Wolf, D., Bader, C. S., Barreras, H., Copsel, S. N., Pfeiffer, B. J., Lightbourn, C. O., Altman, N. H., Komanduri, K. V., & Levy, R. B. (2018) · JCI Insight · doi:10.1172/jci.insight.121717 · Cited by 20

Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients with Acute Myelogenous Leukemia Undergoing Allografting: Assessment of Safety and Tolerability

Michelis, F. V., Hedley, D. W., Malhotra, S., Chow, S., Loach, D., Gupta, V. K., Kim, D. D. H., Kuruvilla, J. G., Lipton, J. H., Viswabandya, A., et al. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.01.014 · Cited by 20

Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma

Lemieux, C., Ahmad, I., Bambace, N. M., Bernard, L., Cohen, S., Delisle, J., Fleury, I., Kiss, T. L., Mollica, L. R., Roy, D., et al. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.09.007 · Cited by 18

Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide

Mariotti, J., Taurino, D., Marino, F., Bramanti, S., Sarina, B., Morabito, L., Philippis, C. D., Vito, C. D., Mavilio, D., Carlo‐Stella, C., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2607 · Cited by 21

Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party

Bazarbachi, A. H., Hamed, R. A., Labopin, M., Hałaburda, K., Labussière, H., BERNASCONI, P. P., Schroyens, W., Gandemer, V., Schaap, N. P., Loschi, M. L., et al. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-01135-3 · Cited by 20

TRANSPLANTATION Hematopoietic cell transplantation (HCT)–specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Sorror, M. L., Maris, M. B., Storb, R. F., Baron, F., S, B. M., Maloney, D. G., & Storer, B. E. (2016)

Assignment of scores for the hematopoietic cell transplantation comorbidity index: integer vs exact weights

Sorror, M. L., Storer, B. E., & Storb, R. F. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.131 · Cited by 9

54: Hematopoietic cell transplantation-comorbidity index (HCT-CI)

Kassar, M., Shell, K., Gregory, S. A., Venugopal, P., Shammo, J. M., & Fung, H. C. H. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.12.057

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Kato, R., Fukuda, T., Usui, E., Yamasaki, S., Maruyama, D., Morita, Y., Kim, S., Mori, S., Tanosaki, R., Tajima, K., et al. (2005) · Blood · doi:10.1182/blood.v106.11.2731.2731 · Cited by 1

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study

Sorror, M. L., Logan, B. R., Zhu, X., Rizzo, J. D., Cooke, K. R., McCarthy, P. L., Ho, V. T., Horowitz, M. M., & Pasquini, M. C. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.04.004 · Cited by 222